WHO / Ahmed Jallanzo
On 26 February 2021 Nurse N'dore Kassie prepares to administer a dose of the rVSV-ZEBOV Ebola vaccine to a woman in the community of Gouéké.
© Credits

Follow-up Meeting: A WHO Strategic Agenda for Filovirus Research and Monitoring (AFIRM)

17 May 2022 14:00 – 16:00 CET

The WHO R&D Blueprint team organized a follow-up consultation to discuss the WHO Strategic Agenda for Filovirus Research and Monitoring (AFIRM). The meeting took place on Tuesday, 17 May 2022 from 14:00 to 16:00 CET (Geneva time).

PRESENTERS/PANEL MEMBERS

Invited experts included:

  • Leading researchers on filovirus basic and translational research
  • Global experts on evidence synthesis and critical appraisal of evidence
  • Regulatory authorities
  • Vaccine developers


Three breakout sessions were held simultaneously to review the

  1. Anticipation of future outbreaks,
  2. Reinforcement of vaccination coverage, and
  3. Cure of filovirus diseases.

 

RELEVANT DOCUMENTS for the meeting:

Agenda: AFIRM Follow-up Meeting Agenda 17 May 2022

Meeting Questions: AFIRM Follow-up Meeting Questions

Report: AFIRM Meeting Report 30 March 2022

 

PRESENTATIONS:

Related

Call for public consultation  ̶  A WHO-Strategic Research Agenda for Filovirus Research and Monitoring (WHO-AFIRM)

This is the last draft version of the WHO R&D Blueprint Filovirus Roadmap, which is now open for suggestions and your expert input would be most welcome.

Please use the following link to submit your feedback:  

WHO-AFIRM Strategy Roadmap 2021-2031